Jonathan Courtland Carlson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fatigue | 2 | 2024 | 1555 | 1.100 |
Why?
|
Cyclooctanes | 7 | 2024 | 37 | 1.040 |
Why?
|
Fluorescent Dyes | 8 | 2024 | 1926 | 0.900 |
Why?
|
Hyperhidrosis | 1 | 2024 | 34 | 0.900 |
Why?
|
Pancytopenia | 1 | 2024 | 102 | 0.860 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2024 | 119 | 0.850 |
Why?
|
Tetrazoles | 3 | 2024 | 923 | 0.830 |
Why?
|
Paresthesia | 2 | 2019 | 160 | 0.750 |
Why?
|
Click Chemistry | 5 | 2024 | 101 | 0.710 |
Why?
|
Delusions | 2 | 2019 | 301 | 0.680 |
Why?
|
Tetrahydrofolate Dehydrogenase | 4 | 2012 | 133 | 0.640 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.490 |
Why?
|
Sweating | 2 | 2024 | 155 | 0.430 |
Why?
|
Boron Compounds | 2 | 2015 | 196 | 0.410 |
Why?
|
Methotrexate | 3 | 2012 | 1722 | 0.360 |
Why?
|
Heterocyclic Compounds | 2 | 2022 | 245 | 0.290 |
Why?
|
Single-Cell Analysis | 5 | 2022 | 2533 | 0.280 |
Why?
|
Staining and Labeling | 4 | 2023 | 1081 | 0.250 |
Why?
|
Nanostructures | 2 | 2008 | 553 | 0.240 |
Why?
|
Molecular Structure | 3 | 2024 | 1884 | 0.230 |
Why?
|
Sweat | 1 | 2024 | 57 | 0.220 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3939 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.180 |
Why?
|
Prodrugs | 1 | 2022 | 275 | 0.170 |
Why?
|
Kinetics | 4 | 2022 | 6333 | 0.170 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 143 | 0.170 |
Why?
|
Anemia, Pernicious | 1 | 2019 | 15 | 0.160 |
Why?
|
Molecular Probes | 1 | 2020 | 309 | 0.160 |
Why?
|
Pyridazines | 1 | 2020 | 203 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 306 | 0.150 |
Why?
|
Exosomes | 1 | 2023 | 430 | 0.150 |
Why?
|
Hemophilia A | 1 | 2021 | 359 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 1 | 2022 | 2475 | 0.150 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 134 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2012 | 3722 | 0.140 |
Why?
|
Hand | 2 | 2019 | 912 | 0.140 |
Why?
|
Escherichia coli | 2 | 2006 | 4211 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2019 | 527 | 0.130 |
Why?
|
Ink | 1 | 2015 | 47 | 0.130 |
Why?
|
Dimerization | 3 | 2010 | 886 | 0.120 |
Why?
|
Vinblastine | 1 | 2016 | 488 | 0.120 |
Why?
|
Fiducial Markers | 1 | 2015 | 134 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1161 | 0.110 |
Why?
|
Chelating Agents | 1 | 2015 | 385 | 0.110 |
Why?
|
Coumarins | 1 | 2014 | 119 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 13020 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2020 | 823 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 2488 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 3 | 2022 | 1132 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2022 | 3139 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2421 | 0.090 |
Why?
|
Spectrometry, Fluorescence | 1 | 2013 | 694 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1755 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4646 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6085 | 0.090 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 450 | 0.090 |
Why?
|
Hydrogels | 1 | 2015 | 745 | 0.080 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9261 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22385 | 0.080 |
Why?
|
Platelet Count | 2 | 2022 | 784 | 0.080 |
Why?
|
Glioblastoma | 1 | 2024 | 3526 | 0.080 |
Why?
|
Antibodies | 3 | 2022 | 2425 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4570 | 0.070 |
Why?
|
Young Adult | 2 | 2024 | 60049 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2012 | 971 | 0.070 |
Why?
|
Mice | 7 | 2022 | 82017 | 0.070 |
Why?
|
Protein Conformation | 2 | 2006 | 3955 | 0.070 |
Why?
|
Humans | 22 | 2024 | 768393 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2955 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5708 | 0.060 |
Why?
|
Endoscopy | 1 | 2015 | 1857 | 0.060 |
Why?
|
Chromatography, Gel | 1 | 2006 | 637 | 0.060 |
Why?
|
Animals | 10 | 2022 | 169337 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 691 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5443 | 0.060 |
Why?
|
Hospitalization | 2 | 2020 | 10844 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3279 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6971 | 0.050 |
Why?
|
Solutions | 1 | 2003 | 409 | 0.050 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 525 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Molecular Conformation | 1 | 2003 | 540 | 0.050 |
Why?
|
Models, Molecular | 3 | 2012 | 5404 | 0.050 |
Why?
|
Thermodynamics | 1 | 2003 | 591 | 0.050 |
Why?
|
Carbamates | 1 | 2022 | 192 | 0.050 |
Why?
|
Amines | 1 | 2022 | 280 | 0.050 |
Why?
|
Isomerism | 1 | 2020 | 198 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 508 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2024 | 3541 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 349 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1402 | 0.040 |
Why?
|
Phenols | 1 | 2022 | 520 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 17135 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2022 | 1605 | 0.040 |
Why?
|
Male | 4 | 2024 | 364902 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Arm | 1 | 2021 | 590 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
Disulfides | 1 | 2020 | 467 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 746 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6017 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23631 | 0.040 |
Why?
|
Edema | 1 | 2021 | 766 | 0.030 |
Why?
|
Carbon | 1 | 2020 | 672 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2225 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4414 | 0.030 |
Why?
|
Ligands | 1 | 2003 | 3283 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2019 | 916 | 0.030 |
Why?
|
Deferoxamine | 1 | 2015 | 155 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6006 | 0.030 |
Why?
|
Zirconium | 1 | 2015 | 110 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1628 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2030 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3579 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4353 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 517 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 669 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1766 | 0.030 |
Why?
|
Immunotherapy | 2 | 2022 | 4738 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2017 | 564 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3088 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2016 | 1216 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15597 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1367 | 0.030 |
Why?
|
Head | 1 | 2019 | 927 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 695 | 0.030 |
Why?
|
Folic Acid Antagonists | 1 | 2012 | 74 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10776 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40272 | 0.020 |
Why?
|
Female | 6 | 2021 | 397089 | 0.020 |
Why?
|
Equipment Design | 1 | 2020 | 3529 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2015 | 2299 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2952 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 657 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 426 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59686 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2012 | 1142 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 489 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8753 | 0.020 |
Why?
|
Nanotubes | 1 | 2010 | 83 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2018 | 2448 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3632 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2636 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 1682 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3857 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 251 | 0.020 |
Why?
|
Radiography | 1 | 2019 | 6993 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1742 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8326 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9371 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3617 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2015 | 1704 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3906 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14737 | 0.020 |
Why?
|
Tacrolimus | 1 | 2010 | 750 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5792 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5103 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12558 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 1057 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2588 | 0.020 |
Why?
|
Laparoscopy | 1 | 2015 | 2056 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4142 | 0.010 |
Why?
|
Sirolimus | 1 | 2010 | 1542 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18362 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10863 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81801 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1967 | 0.010 |
Why?
|
Radiology | 1 | 2015 | 2117 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19022 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 223491 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6670 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24318 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22355 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20765 | 0.010 |
Why?
|
Aged | 2 | 2020 | 171562 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7599 | 0.010 |
Why?
|
Adult | 2 | 2020 | 223640 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11918 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65379 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36849 | 0.010 |
Why?
|